Clinical Trial Update: Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cryoablation with sintilimab and lenvatinib in patients with advanced biliary tract cancer who have previously received immune checkpoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Cryoablation
• Lenvatinib (lenvatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: UNKNOWN